search
clinical researchers
Trends
- 1Clinical Trial Data Exposed in Academic Database Breaches●Clinical trial data including genetic and medical history information has been exposed in academic research database bre
Breaches of academic research databases have exposed clinical trial data, including genetic and medical history information, affecting thousands of trial participants. Privacy advocates are urging people to exercise their rights under HIPAA, which allows patients to obtain their medical records and a list of everyone those records were shared with, and to request corrections where needed.
- 2Highlights from World Cancer Congress 2026, Part Two▼Highlights from World Cancer Congress 2026 – Part 2
Part two of a roundup of highlights from the World Cancer Congress 2026 has been published, covering key presentations, research findings and discussions from the global oncology meeting. The continued coverage suggests sustained interest in developments presented at the congress among cancer researchers and clinicians worldwide.
- 3Epigenetic Editing Moves Closer to Clinical Use▼Epigenetic Editing Steps Closer to the Clinic as Bioengineering Tools Mature
Epigenetic editing, which alters gene activity without changing DNA sequence, is reportedly approaching clinical application as bioengineering tools mature. Advances in gene-regulation technologies are making it feasible to target epigenetic marks precisely, opening the door to therapies for diseases rooted in gene expression rather than genetic mutations. The development signals a shift from laboratory research toward translational medicine, with researchers watching how safety and delivery challenges are addressed.
- 4AI Clinical Monitoring Tool Reported to Cut Trial Costs by Millions▼AI Clinical Monitoring Tool Saves Millions in Trial Costs
An AI-powered clinical monitoring tool is reported to have saved millions of dollars in clinical trial costs, according to coverage in The Scientist. The tool is said to streamline monitoring of trial sites, reducing manual oversight work and associated expenses. The report highlights growing interest in applying artificial intelligence to make drug development faster and cheaper, though detailed figures and trial specifics were not provided.
- 5Could age explain conflicting psychedelic study results?▼Could age help explain why psychedelic studies reach different conclusions?
Researchers are examining whether participants' age may help explain why psychedelic studies reach different conclusions. Older adults may respond differently to psychedelic therapies than younger participants, which could account for variability across trials. The question matters as psychedelics move closer to regulated clinical use for depression and other mental health conditions.
- 6Longevity boom is running ahead of the science●The longevity boom is getting ahead of the science https://www. aljazeera.com/opinions/2026/9/ 27/the-longevity-boom-is-
An Al Jazeera opinion piece argues that the booming longevity industry — anti-ageing treatments, supplements and clinics — is outpacing the scientific evidence behind it. The author warns that commercial hype around extending lifespan is promoting products and promises before rigorous research has validated them, urging caution from consumers and stronger oversight of a rapidly growing wellness market.
- 7Scientists Identify New Potential Target for Hypertension Treatment▼Scientists Discover a New Potential Treatment Target for High Blood Pressure
Researchers have identified a new potential treatment target for high blood pressure, a condition affecting over a billion people worldwide and a leading risk factor for heart disease and stroke. The discovery could open the door to new drug development beyond existing blood pressure medications. Details of the findings and their clinical significance remain limited.
- 8Eric Deutsch on the Fast-Growing Science Linking Radiation Oncology and Immunology▼Eric Deutsch: The Science Is Expanding Fast at the Interface of Radiation Oncology, Immunology, and Technology
Radiation oncology expert Eric Deutsch says science is expanding rapidly at the intersection of radiation therapy, immunology, and technology, as combined approaches such as radiotherapy paired with immunotherapy gain ground in cancer treatment. His remarks highlight how technological advances and immune-based research are reshaping how clinicians think about radiation's role beyond tumour destruction.
- 9Blood test distinguishes bacterial from viral infections in newborns▼Blood test shows whether newborns with fever have bacterial or viral infection
Researchers have developed a blood test that can show whether a newborn with a fever has a bacterial or a viral infection. The advance could help doctors decide quickly whether infants need antibiotics, reducing unnecessary treatment and speeding up care for babies with serious bacterial illness. Medical outlets are reporting on the test's potential to improve diagnosis in newborns, a group in whom infections are hard to distinguish and can become dangerous fast.
- 10Scientists explore growing replacement teeth to regrow lost ones▼Lost a tooth? Science may one day grow it back
Research into tooth regeneration is drawing attention, with reports suggesting science may one day allow people to regrow lost teeth instead of relying on implants or dentures. The work builds on studies of stem cells and the biological mechanisms that form teeth during development, raising hopes for future clinical treatments.